Samsung, Biogen Reach Deal With AbbVie to Sell Near Copy of Humira

Samsung Bioepis said it has reached a settlement with AbbVie that will allow it to market a near-replica version of one of the world’s top-selling drugs Humira.

from WSJ.com: US Business https://ift.tt/2uJZAX2
via IFTTT